Odimont LC Tablet (15 Tab)

Medicine Information

About Odimont LC Tablet:

Odimont LC Tablet is a combination medicine, indicated for relieving symptoms of allergic rhinitis.

Each uncoated bilayered Odimont LC Tablet contains Montelukast Sodium equivalent to Montelukast 10 mg and Levocetirizine Hydrochloride 5 mg.

Montelukast is a selective leukotriene receptor antagonist. Leukotriene type-1 receptor is located on the respiratory airway and on pro-inflammatory cells. It has been correlated with the pathophysiology of asthma and allergic rhinitis. By inhibiting the leukotriene type-1 receptor, Montelukast helps to reduce inflammation in the airways and relieve allergic symptoms.

Levocetirizine is an antiallergic medication that selectively inhibits histamine H1 receptors. This action prevents the negative symptoms associated with histamine release and provides relief from allergic reactions.

Use of Odimont LC Tablet:

Odimont LC Tablet is a combination of Levocetirizine and Montelukast, which is prescribed to relieve symptoms associated with allergic rhinitis (seasonal and perennial).

Usage Direction of Odimont LC Tablet:

• Odimont LC Tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
• Odimont LC Tablet is taken whole with the help of water.
• Do not crush, chew or break the tablet.
• Do not skip or stop the medicine without the physician’s advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Odimont LC Tablet:

• If hypersensitive or allergic to Odimont LC Tablet, inform the physician immediately.
• If found any other complications, inform the physician immediately.
• The Physician should be well informed when concomitant consumption of this tablet with any other medicines or supplements.
• Consult with the physician during pregnancy & lactation.
• Keep out of reach of children.

Storage condition of Odimont LC Tablet:

• Store below 30°C in a dry place. Protect from light and moisture.